1 result
  • provenge

    (sipuleucel-T)
    Dendreon Pharmaceuticals LLC
    PROVENGE® (sipuleucel-T) is indicated for treating asymptomatic or minimally symptomatic metastatic castrate-resistant prostate cancer.